On-demand education

eUROGEN webinar: Genetics of ARM

Dr. Sajjad Rahnama'i explains neurogenic detrusor overactivity

The infertile male in front of a therapeutic dilemma: Surgery or assisted reproductive technology (ART)

Dr. Richard Cathomas about Immunotherapy in muscle-invasive bladder cancer

Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 2

New insights in treatment of bladder cancer: From localised to metastatic diseases

Prof. Nicolas Mottet about the changes in the 2022 guidelines for prostate cancer - Part 1

Laparoscopy

Megaureter – A focus on patient selection and long-term care

Heat-Free robotic treatment of Benign Prostatic Obstruction – from vision to reality?

Prof Daniel Engeler discusses important aspects in the diagnosis and treatment of Chronic Pelvic Pain

Advanced Prostate Cancer – Non-Metastatic Hormone-Sensitive Prostate Cancer (nmHSPC)

PARP inhibitors in prostate cancer. Part 2

Paradigm shifts in metastatic hormone sensitive prostate cancer (mHSPC): Recent treatment developments

Management of Non-metastatic Castration Resistant Prostate Cancer (nmCRPC): Putting current evidence into practice
